These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor. Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127 [TBL] [Abstract][Full Text] [Related]
3. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections. Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561 [No Abstract] [Full Text] [Related]
4. Sensitization against non-HLA antigens following bone marrow graft rejection. Opelz G; Territo MC; Gale RP; Sparkes R Tissue Antigens; 1977 Apr; 9(4):209-19. PubMed ID: 17932 [TBL] [Abstract][Full Text] [Related]
5. Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Parkman R; Rappeport J; Camitta B; Levey RH; Nathan DG Blood; 1978 Dec; 52(6):1163-9. PubMed ID: 363204 [TBL] [Abstract][Full Text] [Related]
6. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia. Tsoi MS; Warren RP; Storb R; Witherspoon RP; Mickelson E; Giblett ER; Schanfield MS; Weiden P; Thomas ED Exp Hematol; 1983 Jan; 11(1):73-81. PubMed ID: 6219886 [TBL] [Abstract][Full Text] [Related]
7. Successful bone marrow transplantation in sensitized recipients. Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor. Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594 [No Abstract] [Full Text] [Related]
9. Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia. Mickelson EM; Fefer A; Storb R; Thomas ED Transplantation; 1976 Sep; 22(3):294-302. PubMed ID: 135386 [TBL] [Abstract][Full Text] [Related]
11. Possible rejection of an HL-A identical sibling renal allograft. d'Apice JF; Morris PJ; Kincaid-Smith P; Mathew TH; Marshall VC Med J Aust; 1976 Feb; 1(7):195-7. PubMed ID: 131902 [TBL] [Abstract][Full Text] [Related]
12. [Transplantation of bone marrow selected by HL-A and MLC-antigens into a patient with aplastic anemia]. Baranov AE; Gus'kova AK; Kaliuta BA; Nadezhina NM; Piatkin EK Probl Gematol Pereliv Krovi; 1975 Dec; 20(12):28-32. PubMed ID: 781663 [No Abstract] [Full Text] [Related]
13. Association of lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) with bone-marrow graft rejection in HLA-identical siblings. Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED Transplant Proc; 1978 Jun; 10(2):433-4. PubMed ID: 354133 [No Abstract] [Full Text] [Related]
14. Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings. Mickelson EM; Clift RA; Fefer A; Storb R; Thomas ED; Warren RP; Hansen JA Transplantation; 1981 Aug; 32(2):90-5. PubMed ID: 6457424 [TBL] [Abstract][Full Text] [Related]
15. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333 [TBL] [Abstract][Full Text] [Related]
16. Third party mixed-leukocyte culture test: a potential new method of histocompatibility testing. Park BH; Good RA Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1490-3. PubMed ID: 4113869 [TBL] [Abstract][Full Text] [Related]
17. Studies on non HL-A cytotoxic and blocking factor in a patient with immunological deficiency successfully reconstituted by bone marrow transplantation. Jeannet M; Rubinstein A; Pelet B Tissue Antigens; 1973; 3(6):411-6. PubMed ID: 4130126 [No Abstract] [Full Text] [Related]
18. Successful bone marrow transplantation against mixed lymphocyte culture barrier. Feig SA; Opelz G; Winter HS; Falk PM; Neerhout RC; Sparkes R; Gale RP Blood; 1976 Sep; 48(3):385-91. PubMed ID: 8180 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease. Filipovich AH; Ramsay NK; Arthur DC; McGlave P; Kim T; Kersey JH Transplantation; 1985 Mar; 39(3):282-5. PubMed ID: 3156437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]